A multicenter longitudinal study of cholinergic subgroups in Parkinson disease
Abstract Parkinson disease (PD) is a heterogeneous syndrome. There is a need for biology-driven subtyping to inform specific therapeutic strategies. In a two-center study with de novo and established PD cohorts, we use vesicular acetylcholine transporter ligand [18F]FEOBV brain PET to assess choline...
Saved in:
| Main Authors: | Nicolaas I. Bohnen, Stiven Roytman, Sygrid van der Zee, Giulia Carli, Fotini Michalakis, Austin Luker, Sofie Slingerland, Kirk A. Frey, Peter J. H. Scott, Robert A. Koeppe, Teus van Laar, Roger L. Albin, Prabesh Kanel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60815-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET study
by: N. Paalanen, et al.
Published: (2025-01-01) -
Editorial: Neuroimaging in psychiatry 2023: neurodegenerative disorders
by: Jannik Prasuhn, et al.
Published: (2025-07-01) -
The Role of Basolateral Amygdalar Cholinergic Neuromodulation in Emotional Learning
by: Victor Manuel Torres-Garcia, et al.
Published: (2025-06-01) -
Post-traumatic cognitive disorders: the cholinergic therapy options
by: O. S. Levin, et al.
Published: (2024-06-01) -
Association of a Brief Computerized Cognitive Assessment With Cholinergic Neurotransmission: Assessment Validation Study
by: Mouna Attarha, et al.
Published: (2025-07-01)